MARKET

PHAR

PHAR

Pharming Group N.V.
NASDAQ
10.44
-0.33
-3.06%
After Hours: 10.59 +0.15 +1.44% 19:30 09/24 EDT
OPEN
10.59
PREV CLOSE
10.77
HIGH
10.64
LOW
10.36
VOLUME
31.87K
TURNOVER
--
52 WEEK HIGH
21.34
52 WEEK LOW
9.62
MARKET CAP
738.92M
P/E (TTM)
57.74
1D
5D
1M
3M
1Y
5Y
1D
Canaccord Genuity Reaffirms Their Buy Rating on Pharming Group (PHAR)
TipRanks · 1d ago
Pharming Group Price Target Maintained With a $37.00/Share by HC Wainwright & Co.
Dow Jones · 2d ago
HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target
Benzinga · 2d ago
Analysts’ Top Healthcare Picks: The Ensign Group (ENSG), Pharming Group (PHAR)
TipRanks · 2d ago
Pharming’s initial Phase 2 Leniolisib data ‘encouraging,’ says H.C. Wainwright
TipRanks · 2d ago
Pharming announces ‘positive’ Phase 2 topline data for leniolisib in PIDs
TipRanks · 2d ago
Weekly Report: what happened at PHAR last week (0914-0918)?
Weekly Report · 3d ago
U.S. 10 Year tops 5% for the first time since October of 2023
Seeking Alpha · 09/14 14:47
More
About PHAR
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Webull offers Pharming Group NV - ADR stock information, including NASDAQ: PHAR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAR stock methods without spending real money on the virtual paper trading platform.